Cardiovascular diseases (CVDs) represent a significant challenge in global health,
demanding advancements in diagnostic modalities. This review delineates the progressive …

Cardiovascular disease remains the leading cause of death worldwide, with mortality rates
increasing annually. This underscores the urgent need for accurate diagnostic and …

Heart failure (HF) is a chronic cardiovascular disease that represents main cause of mortality
worldwide, particularly for elderly. N-terminal pro-brain natriuretic peptide (NT-proBNP) was …

In the context of the high risk of heart failure (HF), rapid assessment of biomarker levels in
patients appears to be a quick and accurate approach to diagnosis and timely treatment …

Heart failure (HF) is the number one cause of death in the world. B-type natriuretic peptide
(BNP) is a recognized biomarker for HF and can be used for early detection. Field effect …

Cardiovascular diseases (CVDs), especially chronic heart failure, threaten many patients'
lives worldwide. Because of its slow course and complex causes, its clinical screening …

Heart failure (HF) is an emerging epidemic and remains a major clinical and public health
problem. Advances in the healthcare management of HF may lead to lower morbidity and …

Abstract terminal pro-brain natriuretic peptide (NT-proBNP) has been demonstrated to be as
a sensitive and specific biomarker for the heart failure (HF) management, while the …

A novel photochemical technological route for one-step functionalization of a graphene
surface with an azide-modified DNA aptamer for biomarkers is developed. The methodology …

Currently, sensitive and accurate approaches for diagnosis, rapid assessment, and cardiac
biomarker monitoring in patients with heart failure are needed. In this context, the …